Trial Profile
Effect of deferasirox in patients de novo AML who were about to receive for hematopoietic stem cell transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2015
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Acute myeloid leukaemia
- Focus Pharmacodynamics
- 10 Apr 2015 New trial record